Abstract
PNS and CNS myelin contain large amounts of galactocerebroside and sulfatide with 2-hydroxylated fatty acids. The underlying hydroxylation reaction is catalyzed by fatty acid 2-hydroxylase (FA2H). Deficiency in this enzyme causes a complicated hereditary spastic paraplegia, SPG35, which is associated with leukodystrophy. Mass spectrometry-based proteomics of purified myelin isolated from sciatic nerves of Fa2h-deficient (Fa2h−/−) mice revealed an increase in the concentration of the three proteins Cadm4, Mpp6 (Pals2), and protein band 4.1G (Epb41l2) in 17-month-old, but not in young (4 to 6-month-old), Fa2h−/− mice. These proteins are known to form a complex, together with the protein Lin7, in Schmidt-Lanterman incisures (SLIs). Accordingly, the number of SLIs was significantly increased in 17-month-old but not 4-month-old Fa2h−/− mice compared to age-matched wild-type mice. On the other hand, the relative increase in the SLI frequency was less pronounced than expected from Cadm4, Lin7, Mpp6 (Pals2), and band 4.1G (Epb41l2) protein levels. This suggests that the latter not only reflect the higher SLI frequency but that the concentration of the Cadm4 containing complex itself is increased in the SLIs or compact myelin of Fa2h−/− mice and may potentially play a role in the pathogenesis of the disease. The proteome data are available via ProteomeXchange with identifier PXD030244.
Introduction
Schmidt-Lanterman incisures (SLIs), also known as myelin incisures or Schmidt-Lanterman clefts, are cytoplasmic channels of the Schwann cells in the myelin internodes. It is generally assumed that SLIs facilitate transport of metabolites, ions, and signaling molecules between peri-nuclear and adaxonal cytoplasmic regions by reducing diffusion distances because of radial diffusion through gap junctions [1].
Galactosylceramide and its sulfated derivative sulfatide are abundant sphingolipids in the nervous system [2]. A large percentage of galactosylceramide and sulfatide in CNS and PNS myelin of mammals contains 2-hydroxylated fatty acyl residues [3, 4]. In myelinating cells, the 2-hydroxylation reaction is exclusively catalyzed by the enzyme fatty acid 2-hydroxylase (FA2H), a cytochrome b5 domain-containing enzyme of the endoplasmic reticulum [5, 6]. Although free fatty acids are substrates for the enzyme in an in vitro activity assay [7], X-ray structural analyses suggest that ceramides may be additional in vivo substrates [8]. The functional role of the 2-hydroxylation modification of sphingolipids is not fully understood. Hydroxylated sphingolipids appear to have unique roles in signal transduction [9] and may affect the turnover of membrane proteins by their influence on the mobility of lipids in membrane subdomains (or lipid rafts) [10,11,12].
Mutations in the FA2H gene that reduce or abolish activity of the enzyme cause a complicated form of hereditary spastic paraplegia type 35 (SPG35) associated with leukodystrophy, which is also known as fatty acid hydroxylase-associated neurodegeneration (FAHN) and as a subtype of neurodegeneration with brain iron accumulation (NBIA) [13]. More than 40 disease-associated human FA2H mutations have been reported [14]. Fa2h-deficient (Fa2h−/−) mice serve as animal model of SPG35/FAHN and develop a phenotype that is reminiscent of symptoms of the human disease [15, 16]. In a previous study, we found evidence for alterations in the CNS myelin proteome of Fa2h−/− mice [17]. Although SPG35, like hereditary spastic paraplegias in general, is characterized by degeneration of upper motor neurons, peripheral neuropathy has been described in about 30% of the patients [14]. Karle et al. [18] estimated a prevalence of peripheral neuropathy of about 60% in all cases of hereditary spastic paraplegia together. In the present report, we performed a myelin proteome study of sciatic nerves, in order to examine possible molecular changes in the PNS myelin of Fa2h−/− mice.
Experimental Procedures
Animals
Generation of Fa2h−/− mice (Fa2htm1Meck; MGI:3829000) and genotyping has been described previously (Zöller et al., 2008). Animal experiments have been approved by the national authorities (reference number: 84–02.04.2014-A039).
Antibodies
Antibodies used in this study are listed in Table 1 and were kind gifts from Peter Prophy and Arthur M. Butt or were purchased from the following companies: Abcam (Cambridge, UK), Antibodies Incorporated (Davis, California, USA), Biorbyt (Cambridge, UK), GeneTex (Irvine, California, USA), Jackson ImmunoResearch (Philadelphia, Pennsylvania, USA), Merck (Darmstadt, Germany), and Thermo Fisher (Waltham, Massachusetts, USA).
Purification of Myelin from Sciatic Nerves
Myelin from sciatic nerves was isolated according to Caroni and Schwab [19] with the following modifications. Sciatic nerves were removed from mice that had been killed by cervical dislocation and stored at − 80 °C, before they were homogenized in isotonic 9.2% sucrose solution using a Dounce homogenizer (pooled nerves from one mouse). Myelin was then purified by sucrose density step gradient (9.2% and 28.4% sucrose) centrifugation. Myelin isolated from the interphase was washed with water, resuspended in 1-mM EDTA, and stored at − 80 °C.
Lipid Extraction and Thin Layer Chromatography
Total lipid extracts from sciatic nerves were prepared as described [20]. Briefly, nerves were homogenized in methanol using a Dounce homogenizer, and then chloroform and 1% HClO4 were added to obtain a final ratio of 1:1:0.9 (chloroform/methanol/HClO4; v/v/v). Samples were mixed and centrifuged to facilitate phase separation. The organic phase was dried in a vacuum centrifuge, dissolved in chloroform/methanol (1:1; v/v), and sonicated (5 min) in a sonication water bath. Aliquots of the lipids were administered to silica gel 60 HPTLC plates (Merck) and separated in a solvent-saturated chromatography tank using chloroform/methanol/water (70:30:4; v/v/v) as solvent system. Lipids were stained by spraying TLC plates with a solution of 625-mM cupric sulfate, 8% phosphoric acid, followed by heating to 150 °C for 5 min [21].
SDS-PAGE and Silver Staining
SDS-PAGE (10% or 12.5% acrylamide) under reducing conditions was performed as described [17]. Silver staining was performed according to Heukeshoven and Dernick [22].
Western Blot Analysis
Semi-dry Western blotting on 0.1-µm nitrocellulose membranes (GE Healthcare, Chicago, Illinois, USA) was performed as described [17] using the transfer buffer 25-mM Tris, 192-mm glycine, 20% methanol, and pH 8.3 [23]. Transfer conditions were 25 V, 30 min or 2 mA/cm2, 70 min. Transfer efficiency was monitored by Ponceau S staining [24]. Membranes were blocked in 3% milk, 0.05% Tween 20, 20-mM Tris–HCl, 150-mM NaCl, and pH 7.4 and stained with primary antibodies in blocking solution (4 °C, overnight), followed by appropriate peroxidase-conjugated secondary antibodies (see Table 1 for antibodies used and dilutions).
Mass Spectrometry and Data Analysis
Tandem mass tag 6-plex (TMTsixplex) labeling and liquid chromatography-tandem mass spectrometry (LC–MS/MS) measurements were performed as described previously [17]. Briefly, purified myelin samples were delipidated by acetone precipitation and then subjected to RapiGest (Waters, Milford, Massachusetts, USA) assisted tryptic digestion (enzyme to protein ratio = 1:100) including cysteine reduction and alkylation. Afterwards, peptides were labeled using TMTsixplex Isobaric Label Reagent (Thermo Fisher) and then combined into three labeling pools, with each pool containing one independent biological replicate of 6-, 13-, and 17-month-old wild-type and Fa2h−/− mice. Thereafter, RapiGest was precipitated, samples desalted by solid-phase extraction, and each sample pool subjected to 12 well OFFGEL fractionation. Finally, all peptide fractions were separated by reversed phase chromatography (self-packed column: 100 µm × 200 mm, Magic C18 AQ, 5 µm, Bruker, Bremen, Germany) using an Easy-nLC 1000 UHPLC (Thermo Fisher) and analyzed by a data-dependent TOP10 method using a LTQ Orbitrap Velos mass spectrometer (Thermo Fisher). Raw files were processed with Proteome Discoverer 2.5 (Thermo Fisher) in combination with a Mascot 2.6.1 (Matrix Science, London, UK) search engine. Initially, MS1 precursor masses were recalibrated with the Spectrum Files RC node (Tolerances MS1/2: 20 ppm/0.02 Da) using a non-linear regression model. Spectra were searched against a Swissprot Mus musculus proteome database (downloaded 03/2021, 17085 entries) and two common contaminants database, cRAP (https://www.thegpm.org/crap/) and MaxQuant-contaminants (https://maxquant.org), in a reverse decoy approach. The enzyme specificity was Trypsin/P with up to two missed cleavages allowed. TMTsixplex was set as quantification method. Modifications were propionamide (C) and TMT (K, Peptide N-term) as fixed and oxidation (M) and acetylation (Protein N-term) as variable. Search tolerances were 20 ppm both for MS1 and MS2. Identified spectra (PSM) were validated by the Percolator node based on q-values to target false discovery rates (FDRs) of 1%/5% FDR (strict/relaxed). All spectra not passing the stricter FDR were submitted to a second-pass Mascot search employing relaxed parameters:
-
Enzyme name: SemiTrypsin
-
Max. missed cleavages: 1
-
Dynamic mods: oxidation (M), acetylation (Protein N-term), propionamide (C), TMT (K, Peptide N-term)
After PSM validation by Percolator, the combined PSMs were aggregated to peptides and proteins according to the principle of strict parsimony and finally filtered at 1% peptide and protein FDR. In addition, the protein list was filtered to contain only master proteins. For quantification, TMT reporter ion signals were extracted at the MS2 level with 20 ppm tolerance using the most confident centroid. From this, the relative peptide/protein quantification was achieved using the following parameters:
-
Peptides to use: unique + razor
-
Reporter abundance based on intensity
-
Co-isolation threshold: 30%
-
Average reporter S/N: 10.
The resulting protein list was filtered for master proteins only and exported to R Studio (R version 4.1.0) for data processing, differential expression analysis, and visualization using the following additional packages: BioVenn 1.1.3, dplyr 1.0.8, EnhancedVolcano 1.12.0, ggplot2 3.3.5, ggrepel 0.9.1, limma 3.50.0, and pheatmap 1.0.12. First, contaminating proteins were removed including proteins labeled “Ig.” After log(2) transformation, data was filtered for proteins containing three intensity values for each age and genotype. The filtered data was then normalized by cyclic loess normalization, and differentially abundant proteins were determined by a moderated t test based on linear models (limma trend) [25]. To account for batch effects of individual TMT batches, batch was included as co-variate in the linear model. Finally, contrast for all relevant comparisons were extracted from the linear model and exported to individual result tables. Note that proteins with an absolute log(2)-fold change > 0.585 and a false discovery rate (FDR) < 0.1 were deemed significantly regulated. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [26] partner repository with the dataset identifier PXD030244 and 10.6019/PXD030244.
Teased Fiber Preparation and Immunostaining
Sciatic nerves were immersion fixed in 4% paraformaldehyde in PBS, washed with PBS, and stored at 4 °C in PBS containing 0.02% sodium azide. Teased fibers were prepared as described [27] and dried overnight at room temperature. For quantification of SLIs, teased fibers were stained with Atto488-labeled phalloidin (Sigma-Aldrich, St. Louis, Missouri, USA). For immunofluorescence staining, teased fibers were post fixed and permeabilized in − 20 °C cold methanol for 15 min. After blocking with 2% bovine serum albumin and 0.3% Triton X-100 in PBS at 25 °C for 2 h, specimens were incubated with primary antibodies overnight at 4 °C in a moisturized chamber. After washing 6 times with PBS, specimens were stained with the appropriate secondary antibodies for 2 h at 25 °C (see Table 1 for antibodies and dilutions). Microscopic pictures were captured using an Axiovert 200 M microscope fitted with a Colibri LED system (Carl Zeiss, Jena, Germany). Length of nodes of Ranvier and paranodes in microscopic pictures were measured using the ZEN 3.2 software or Axiovision SE64 Rel. 4.9.1 (both from Carl Zeiss).
Statistical Analysis
Data are presented as mean ± standard deviation (SD). Data were tested for normal distribution by Shapiro–Wilk test. Normal distributed data were analyzed by Student t test. A p value < 0.05 was considered statistically significant. In case of multiple comparisons, the FDR was controlled according to Benjamini and Hochberg [28]. For the proteome analysis, a FDR of 0.1 was chosen because of the exploratory nature of the study; otherwise the FDR was controlled at level 0.05.
Results
Proteome Analysis of Sciatic Nerve Myelin from Fa2h−/− Mice Showed Increased Levels of Four Proteins that Are Known to Form a Complex in SLIs
Myelin was isolated from sciatic nerves of Fa2h−/− and Fa2h+/+ mice (aged 6, 13 and 17 months) by sucrose density gradient centrifugation. Purification and comparability of myelin samples were monitored by lipid analysis (Fig. 1a) and SDS-PAGE followed by silver staining (Fig. 1b). In line with previous analyses of sciatic nerves [15], 2-hydroxylated galactosylceramide and sulfatide were absent from Fa2h−/− mice, whereas their non-hydroxylated isoforms were increased, resulting in only small changes in the levels of total galactosylceramide and sulfatide (Fig. 1a). In addition, levels of major myelin proteins were examined by Western blotting (Fig. 1c), which showed comparable concentrations of periaxin, 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), large isoform of myelin-associated glycoprotein (L-MAG), and myelin basic protein (MBP).
Sciatic nerve myelin purification. A Lipid thin layer chromatography of total lipid extracts isolated from purified myelin confirmed absence of 2-hydroxylated fatty acid containing galactosylceramide (hfa-GalC) and sulfatide (hfa-sulf) in Fa2h−/− mice (nfa, non-hydroxylated fatty acid). B Representative silver staining of purified PNS myelin samples separated by SDS-PAGE. C Western blot analysis of purified myelin samples from 6 and 17-month-old mice showed comparable levels of major PNS myelin proteins: CNP, L-MAG, Periaxin, and MBP. D Densitometric quantification of Western blots. Intensities were normalized to periaxin. Data shown are the mean ± SD (n = 3 mice per genotype) with the mean of wild type set to 1; p values for t test
Mass spectrometry of three biological replicates per age group was performed as previously described [17]. In total, 1418 protein groups could be identified in at least one biological replicate, and 937 protein groups could be identified in at least two replicates per age group (data have been deposited at the PRIDE partner repository with the dataset identifier PXD030244 and 10.6019/PXD030244). Major myelin proteins showed high abundance, as expected (Fig. 2a). After filtering the data to remove all protein groups not identified in all data sets, 681 proteins remained for quantitative evaluation (Supplementary Table S1). Compared with a list of 90 well-known myelin proteins identified in previous PNS myelin proteome studies [29, 30], our approach identified 59% of them in all samples. When compared with the myelin proteome data set published by Siems et al. [28], 74% of those proteins could be identified in our study and 47% were identified and quantified in all samples (Fig. 2b, c). Samples from 13-month-old mice were excluded from further analysis, because cluster analysis and principal component analysis revealed inconsistencies in the results for this age group with these samples for unclear reasons (supplementary Fig. S1).
Myelin proteome analysis of sciatic nerves isolated from Fa2h−/− mice. A Protein abundance plot showing the log(10) intensity for all 681 proteins that could be identified in all samples averaged over all samples. Known myelin proteins are highlighted in blue and a selection is labeled with their respective gene name. B Venn diagram comparing the PNS myelin proteins identified (in one replicate) in this study with the data published in Siems et al. [28] (dataset UDMSE, Fif1-data1-v1, 1). C Venn diagram comparing the PNS myelin proteins reliably identified (filtered IDs, abundance values in all replicates) in this study with the data published by Siems et al. [28] (dataset UDMSE, Fif1-data1-v1, 1). D, E Vulcano plot of myelin proteome data from 6-month-old (D) and 17-month-old mice (E). Data points show the -log10 transformed p-value versus median of the log2(fold change) (+ = increased in Fa2h−/−;—= decreased in Fa2h−/−) for proteins identified in all replicates. Proteins known to be present in SLIs are highlighted in orange and other known myelin proteins (according to Patzig et al. [29]) in blue. Selected myelin proteins are labeled with the corresponding gene names. Vertical broken lines indicate the 0.666- or 1.5-fold change thresholds. The horizontal line in (E) indicates the significance threshold when the FDR was controlled at level 0.1
We then tested for significantly altered proteins using a moderated t-test based on linear models (limma). After correction for multiple comparisons, significant changes (using the criteria: |log(2)(fold change)|≥ 0.585 and a FDR of 0.1) were not observed in 6-month-old mice (Fig. 2D). In contrast, in 17-month-old Fa2h−/− mice, 21 proteins were significantly changed, among them only few established myelin proteins (Fig. 2E, Table 2). Notably, three myelin proteins showed a very similar, approximately 50% increase in 17-month-old Fa2h−/− mice: Cadm4 (SynCAM4, Necl4), protein band 4.1G (Epb41l2), and Mpp6 (Pals2). The protein Lin7 (Lin7c) showed a similar increase (Fig. 2E), though this was statistically not significant. These four proteins are known to form a tetrameric complex in the membrane cytoskeleton of SLIs [31, 32]. The similar relative increase of all four proteins strongly suggests that they are mainly present in a complex in myelin, which is increased in the PNS of Fa2h−/− mice.
Western blot analysis was used to confirm the mass spectrometry results using independent myelin samples isolated from sciatic nerves of young and old mice (Fig. 3). These experiments confirmed (1) unaltered levels of Cadm4, Lin7, and Mpp6 in young (4 to 6-month-old) Fa2h−/− mice (Fig. 3a) and (2) a significant increase of Cadm4, Lin7, and Mpp6 in 17- to 18-month-old Fa2h−/− mice (Fig. 3b) (we were unable to detect protein band 4.1G by Western blotting using commercially available antibodies).
Cadm4, Mpp6 and Lin7 protein levels are in increased in old Fa2h−/− mice. Western blot analysis of purified myelin from 4 to 6-month-old A and 17-month-old B Fa2h+/+ and Fa2h−/− sciatic nerves. Blots were stained with the indicated antibodies and Western blot data from three or four independent samples (n = 3–4 mice per genotype) were evaluated by densitometry. Densitometric data were normalized to periaxin, except periaxin, which was not normalized. Data shown are the mean ± SD (n = 3–4) with the mean of wild type set to 1. p values in bold are significant (after control of the FDR at level 0.05)
Increased Numbers of SLIs in Old but Not Young Fa2h−/− Mice
Potentially, the results from the proteome analysis could indicate an increase in the number of SLIs. On the other hand, however, other proteins known to be present in SLIs and identified by in our mass spectrometry screen were not increased in Fa2h−/− mice (see Fig. 2E), and Western blot analysis showed no significantly altered levels of L-MAG (see Fig. 1c, d), which is also abundant in SLIs [33]. SLIs were quantified in teased fibers of sciatic nerves using fluorescently labeled phalloidin (Fig. 4a). The number of SLIs was significantly increased by 22% in 17-month-old (p = 0.0154, t-test) but not in young (4-month-old; p = 0.7873) Fa2h−/− mice (Fig. 4B). Only axons with a comparable internode width were evaluated (Fig. 4C). The small but significant increase of SLI frequency was lower than expected from the relative increase of Cadm4, Lin7, Mpp6, and band 4.1G protein observed by mass spectrometry or Western blot analysis (≥ 50% increase). In line with their presence in the same molecular complex, Cadm4 and Lin7 colocalized in teased fibers and were mostly present in SLIs (Fig. 4D). We found no evidence for an altered distribution in Fa2h−/− compared to Fa2h+/+ mice.
SLI frequency is increased in old Fa2h−/− mice. A Phalloidin staining of teased fibers from 17-month-old Fa2h+/+ and Fa2h−/− mice. B Quantification of SLI frequencies in teased fibers of sciatic nerves from 4-month-old (n = 5 mice per genotype; N = 50 fibers analyzed) and 17-month-old mice (n = 7 mice per genotype; N = 70 fibers). The number of SLIs was significantly increased in old but not young Fa2h−/− mice. p value in bold indicates significant difference (t-test). C The average internodal diameter of axons examined to determine the SLI frequencies was not significantly different between genotypes. All data are shown as mean ± SD (n = 5–7) of the average SLI frequency or internodal diameter per mouse. D Immunofluorescence staining of Cadm4 and Lin7 in teased fibers from 17-month-old Fa2h+/+ and Fa2h−/− mice. Both proteins co-localized and showed a similar distribution (mainly present in SLIs) in both genotypes
Normal Length of Nodes of Ranvier and Paranodes in Fa2h−/− Mice
Because the paranodal structure is disturbed in mice lacking sulfatide [34], we wondered whether absence of 2-hydroxylated sulfatide may also affect the paranodes in older mice. Normal paranodal structure in young Fa2h−/− mice was already demonstrated in a previous report [15]. We determined length of nodes of Ranvier in 17-month-old mice and paranodes using Caspr as paranodal marker [35] (Fig. 5a). No significant differences between genotypes were observed (Fig. 5b, c).
Length of paranodes and nodes of Ranvier are unaltered in Fa2h−/− mice. A Teased fibers of sciatic nerves from 17-month-old Fa2h+/+ and Fa2h−/− mice were stained with antibodies directed against Caspr (to label paranodes) and atto488-conjugated phalloidin to stain actin. The length of the paranodes (Caspr staining) B and the length of the nodes (distance between Caspr clusters) C were determined. No significant differences were observed. Data are shown with the mean ± SD of the average values obtained for each mouse analyzed (n = 3 mice per genotype; N = 30 nodes analyzed)
Discussion
To our knowledge, the currently most comprehensive data set of mouse PNS myelin proteome used a gel- and label-free approach and identify 1083 proteins and could differentially analyze up to 700 proteins in the myelin proteome [29]. Using TMT-labeling for relative quantification, we were able to reproducibly identify and quantify 681 proteins (937 if proteins not detectable in all age groups were included). Thus, the number of identified and quantified proteins is comparable to previous proteome studies. The unique presence of several proteins in the proteome in our and the previous studies [29, 30] may be due to the different methods used, but the different ages analyzed (6 months and older in our study; 3–4 weeks in Patzig et al. [30] and Siems et al. [29]) may also contribute to these differences. Inconsistencies in the data of the 13-month samples that have prompted us to exclude them from further analyses and could be the result of improper TMT-labeling, though other errors in sample preparation cannot be excluded.
The differences between PNS myelin proteomes of Fa2h+/+ and Fa2h−/− mice were small in all age groups examined, and upon focusing on well-established myelin proteins, we observed a rather specific increase of the four proteins Cadm4, Mpp6 (Pals2), Lin7, and band 4.1G (Epb41l2). These four molecules are co-regulated at the protein and mRNA level [29], and there is clear evidence that they form a complex in SLIs [32, 36,37,38]. Localization of this complex in SLIs depends on band 4.1G protein [39]. The almost identical relative upregulation of all four proteins by 50%, as observed in the mass spectrometric analysis strongly suggests that the four proteins are mainly present in this complex in myelin. Because several other myelin proteins known to be present in SLIs [32] were not found to be significantly increased in Fa2h−/− sciatic nerve myelin, we assume that the increased level of the Cadm4 complex does not only reflect the higher SLI frequency. Whether increase in the membrane skeletal complex and the increase in SLI frequency are connected or independent events are unclear at present. A higher SLI frequency in Mpp6-deficient mice [31] indicates at least that changes in the level or localization of components of this membrane skeleton complex can affect SLI frequency, though the mechanism is currently not understood.
An increase in the number of SLIs together with structural abnormalities of the paranodes has also been observed in Ugt8- and Gal3st1-deficient mice, both lacking sulfatide [40,41,42,43]. In contrast to these mice, however, Fa2h−/− mice, which lack only the 2-hydroxylated species of these lipids and have only slightly reduced total sulfatide levels in PNS myelin [15], have apparently normal paranodes at young [15] and old ages (this report). This indicates that sulfatide can fulfill its role at the paranodes irrespective of its hydroxylation status. In addition, the increased SLI frequency in sulfatide-deficient mice is age-independent [43]. We therefore assume that different mechanisms are responsible for the increase of the SLI frequency in Fa2h−/− mice and such lacking sulfatide. The age-dependent increase in the number of SLIs correlates with the late onset of disease in Fa2h−/− mice [15, 16]. Although PNS pathology is not a hallmark of hereditary spastic paraplegia, peripheral neuropathy has been observed in around 30% of SPG35 patients [14]. Because in remyelinated axons, the SLI frequency is increased [44, 45], it is possible that increased number of SLIs in Fa2h−/− mice merely reflects remyelination. Peripheral nerves of 12-month-old Fa2h−/− mice, however, showed thin myelin in less than 1% of axons, suggesting only a low level of de- and remyelination [16]. Therefore, the increased SLI frequency at 17 months may indicate significant peripheral neuropathy and demyelination in older Fa2h−/− mice.
In a previous study with Fa2h−/− CNS myelin, we could identify the oligodendrocytic myelin paranodal and inner loop protein (Opalin, Tmem10) to be significantly increased in myelin from old Fa2h−/− mice [17]. Opalin is exclusively found in CNS myelin but not in PNS myelin [46, 47]. Furthermore, we found evidence for alterations in the transport and turnover of the protein, whereas expression of the Opalin gene was unaffected. These findings suggested that 2-hydroxylated sphingolipids may be required for correct sorting of Opalin and maybe other myelin proteins. Interestingly, Cadm4 was also increased in the CNS myelin proteome from 17-month-old mice according to our mass spectrometry analysis, although the null hypothesis could not be rejected in subsequent Western blot analyses [17]. Cadm4 also interacts with the choline transporter CTL1, and Cadm4-deficiency in Schwann cells leads to elevated levels of long chain and polyunsaturated phosphatidylcholine and phosphatidylinositol [48]. Therefore, elevated Cadm4 levels could potentially affect membrane lipid composition and membrane fluidity.
Because of its membrane topology, only Cadm4 could potentially be directly influenced by changes in the properties of galactosylceramide and sulfatide caused by absent 2-hydroxylation, as both lipids are only found in the extracellular leaflet of the plasma membrane. Further studies should examine if 2-hydroxylated sphingolipids may directly affect turnover and/or sorting of Cadm4 in myelinating Schwann cells. Although the increase of the Cadm4 complex in older mice correlates with the late onset of pathology in Fa2h−/− mice [15, 16], it has to be examined whether increased levels of the Cadm4 containing complex in old Fa2h−/− mice contributes to the pathogenesis of the disease and whether similar changes occur in human patients and may thus play a role in human SPG35.
Data Availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [25] partner repository with the dataset identifier PXD030244 and 10.6019/PXD030244.
Abbreviations
- Cadm4:
-
Cell adhesion molecule 4
- CNP:
-
2',3'-Cyclic nucleotide 3'-phosphodiesterase
- Epb41l2:
-
Erythrocyte membrane protein band 4.1 like 2
- FA2H:
-
Fatty acid 2-hydroxylase
- FDR:
-
False discovery rate
- LC–MS/MS:
-
Liquid chromatography-tandem mass spectrometry
- Lin7:
-
Lin-7 homolog
- L-MAG:
-
Large isoform of myelin-associated glycoprotein
- MBP:
-
Myelin basic protein
- Mpp6:
-
Membrane protein, palmitoylated 6/MAGUK p55 subfamily member 6
- Opalin:
-
Oligodendrocytic myelin paranodal and inner loop protein
- Pals2:
-
Protein associated with LIN7 2
- SD:
-
Standard deviation
- SLI:
-
Schmidt-Lanterman incisure
- SPG35:
-
Spastic paraplegia type 35
- TMTsixplex:
-
Tandem mass tag 6-plex
References
Balice-Gordon RJ, Bone LJ, Scherer SS (1998) Functional gap junctions in the schwann cell myelin sheath. J Cell Biol 142:1095–1104
Eckhardt M (2008) The role and metabolism of sulfatide in the nervous system. Mol Neurobiol 37:93–103
Hoshi M, Williams M, Kishimoto Y (1973) Characterization of brain cerebrosides at early stages of development in the rat. J Neurochem 21:709–712
Hama H (2010) Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta 1801:405–414
Alderson NL, Rembiesa BM, Walla MD, Bielawska A, Bielawski J, Hama H (2004) The human FA2H gene encodes a fatty acid 2-hydroxylase. J Biol Chem 279:48562–48568
Eckhardt M, Yaghootfam A, Fewou SN, Zöller I, Gieselmann V (2005) A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galactosylceramide in myelin. Biochem J 2388:245–254
Alderson NL, Walla MD, Hama H (2005) A novel method for the measurement of in vitro fatty acid 2-hydroxylase activity by gas chromatography-mass spectrometry. J Lipid Res 46:1569–1575
Zhu G, Koszelak-Rosenblum M, Connelly SM, Dumont ME, Malkowski MG (2015) The Crystal Structure of an Integral Membrane Fatty Acid α-Hydroxylase. J Biol Chem 290:29820–29833
Kota V, Hama H (2014) 2’-Hydroxy ceramide in membrane homeostasis and cell signaling. Adv Biol Regul 54:223–230
Guo L, Zhou D, Pryse KM, Okunade AL, Su X (2010) Fatty acid 2-hydroxylase mediates diffusional mobility of Raft-associated lipids, GLUT4 level, and lipogenesis in 3T3-L1 adipocytes. J Biol Chem 285:25438–25447
Guo L, Zhang X, Zhou D, Okunade AL, Su X (2012) Stereospecificity of fatty acid 2-hydroxylase and differential functions of 2-hydroxy fatty acid enantiomers. J Lipid Res 53:1327–1335
Ibarguren M, López DJ, Encinar JA, González-Ros JM, Busquets X, Escribá PV (2013) Partitioning of liquid-ordered/liquid-disordered membrane microdomains induced by the fluidifying effect of 2-hydroxylated fatty acid derivatives. Biochim Biophys Acta 1828:2553–2563
Gregory A, Venkateswaran S, Hayflick SJ (2011) Fatty Acid Hydroxylase-Associated Neurodegeneration. 2011 Jun 28 [updated 2018 Sep 27]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021
Rattay TW, Lindig T, Baets J, Smets K, Deconinck T, Söhn AS, Hörtnagel K, Eckstein KN et al (2019) FAHN/SPG35: a narrow phenotypic spectrum across disease classifications. Brain 142:1561–1572
Zöller I, Meixner M, Hartmann D, Büssow H, Meyer R, Gieselmann V, Eckhardt M (2008) Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J Neurosci 28:9741–9754
Potter KA, Kern MJ, Fullbright G, Bielawski J, Scherer SS, Yum SW, Li JJ, Cheng H et al (2011) Central nervous system dysfunction in a mouse model of FA2H deficiency. Glia 59:1009–1021
Hardt R, Jordans S, Winter D, Gieselmann V, Wang-Eckhardt L, Eckhardt M (2020) Decreased turnover of the CNS myelin protein Opalin in a mouse model of hereditary spastic paraplegia 35. Hum Mol Genet 29:3616–3630
Karle KN, Schüle R, Klebe S, Otto S, Frischholz C, Liepelt-Scarfone I, Schöls L (2013) Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP). Orphanet J Rare Dis 8:158
Caroni P, Schwab ME (1988) Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol 106:1281–1288
Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917
Yao JK, Rastetter GM (1985) Microanalysis of complex tissue lipids by high-performance thin-layer chromatography. Anal Biochem 150:111–116
Heukeshoven J, Dernick R (1985) Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 6:103–112
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350–4354
Korotzer JL, Bergquist LM, Searcy RL (1961) Use of cellulose acetate and Ponceau S for electrophoretic serum protein analysis. Am J Med Technol 27:197–203
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47
Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, Inuganti A, Griss J et al (2019) The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47:D442–D450
Sherman DL, Fabrizi C, Gillespie CS, Brophy PJ (2001) Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30:677–687
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a pratical and powerful approach to multiple testing. J R Statist Soc B 57:289–300
Siems SB, Jahn O, Eichel MA, Kannaiyan N, Wu LMN, Sherman DL, Kusch K, Hesse D et al (2020) Proteome profile of peripheral myelin in healthy mice and in a neuropathy model. Elife 9:e51406
Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K et al (2011) Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci 31:16369–16386
Saitoh Y, Kamijo A, Yamauchi J, Sakamoto T, Terada N (2019) The membrane palmitoylated protein, MPP6, is involved in myelin formation in the mouse peripheral nervous system. Histochem Cell Biol 151:385–394
Terada N, Saitoh Y, Kamijo A, Yamauchi J, Ohno N, Sakamoto T (2019) Structures and Molecular Composition of Schmidt-Lanterman Incisures. Adv Exp Med Biol 1190:181–198
Trapp BD, Quarles RH (1984) Immunocytochemical localization of the myelin-associated glycoprotein. Fact or artifact? J Neuroimmunol 6:231–249
Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, Popko B, Suzuki K et al (2002) A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J Neurosci 22:6507–6514
Menegoz M, Gaspar P, Le Bert M, Galvez T, Burgaya F, Palfrey C, Ezan P, Arnos F et al (1997) Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 19:319–331
Terada N, Saitoh Y, Ohno N, Komada M, Saitoh S, Peles E, Ohno S (2012) Essential function of protein 4.1G in targeting of membrane protein palmitoylated 6 into Schmidt-Lanterman incisures in myelinated nerves. Mol Cell Biol 32:199–205
Terada N, Saitoh Y, Ohno N, Komada M, Yamauchi J, Ohno S (2013) Involvement of Src in the membrane skeletal complex, MPP6-4.1G, in Schmidt-Lanterman incisures of mouse myelinated nerve fibers in PNS. Histochem Cell Biol 140:213–222
Terada N, Saitoh Y, Kamijo A, Ohno S, Ohno N (2016) Involvement of membrane skeletal molecules in the Schmidt-Lanterman incisure in Schwann cells. Med Mol Morphol 49:5–10
Saitoh Y, Ohno N, Yamauchi J, Sakamoto T, Terada N (2017) Deficiency of a membrane skeletal protein, 4.1G, results in myelin abnormalities in the peripheral nervous system. Histochem Cell Biol 148:597–606
Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Suzuki K, Popko B (1996) Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86:209–219
Dupree JL, Coetzee T, Suzuki K, Popko B (1998) Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J Neurocytol 27:649–659
Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, Fukushima K, Fukushima J, Nagasawa T et al (2002) Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci U S A 99:4227–4232
Hoshi T, Suzuki A, Hayashi S, Tohyama K, Hayashi A, Yamaguchi Y, Takeuchi K, Baba H (2007) Nodal protrusions, increased Schmidt-Lanterman incisures, and paranodal disorganization are characteristic features of sulfatide-deficient peripheral nerves. Glia 55:584–594
Ghabriel MN, Allt G (1980) Schmidt-Lanterman Incisures. I. A quantitative teased fibre study of remyelinating peripheral nerve fibres. Acta Neuropathol 52:85–95
Berger BL, Gupta R (2006) Demyelination secondary to chronic nerve compression injury alters Schmidt-Lanterman incisures. J Anat 209:111–118
Golan N, Adamsky K, Kartvelishvily E, Brockschnieder D, Möbius W, Spiegel I, Roth AD, Thomson CE et al (2008) Identification of Tmem10/Opalin as an oligodendrocyte enriched gene using expression profiling combined with genetic cell ablation. Glia 56:1176–1186
Yoshikawa F, Sato Y, Tohyama K, Akagi T, Hashikawa T, Nagakura-Takagi Y, Sekine Y, Morita N et al (2008) Opalin, a transmembrane sialylglycoprotein located in the central nervous system myelin paranodal loop membrane. J Biol Chem 283:20830–20840
Heffernan C, Jain MR, Liu T, Kim H, Barretto K, Li H, Maurel P (2017) Nectin-like 4 Complexes with Choline Transporter-like Protein-1 and Regulates Schwann Cell Choline Homeostasis and Lipid Biogenesis in Vitro. J Biol Chem 292:4484–4498
Acknowledgements
We thank Peter Brophy and Arthur M. Butt for the kind gift of antibodies.
Funding
Open Access funding enabled and organized by Projekt DEAL. This work was supported by a grant of the Deutsche Forschungsgemeinschaft through SFB645 of the University of Bonn (project B5) to M.E.
Author information
Authors and Affiliations
Contributions
Matthias Eckhardt, Dominic Winter, and Robert Hardt contributed to the study conception and design. Experiments and data analysis were performed by Silvia Jordans, Robert Hardt, Ivonne Becker, Lihua Wang-Eckhardt, and Matthias Eckhardt. The first draft of the manuscript was written by Matthias Eckhardt. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Animal experiments have been approved by the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen (reference number: 84–02.04.2014-A039).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Silvia Jordans and Robert Hardt contributed equally to this work.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jordans, S., Hardt, R., Becker, I. et al. Age-Dependent Increase in Schmidt-Lanterman Incisures and a Cadm4-Associated Membrane Skeletal Complex in Fatty Acid 2-hydroxylase Deficient Mice: a Mouse Model of Spastic Paraplegia SPG35. Mol Neurobiol 59, 3969–3979 (2022). https://doi.org/10.1007/s12035-022-02832-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-022-02832-4
Keywords
- Myelin
- Schmidt-Lanterman incisure
- Spastic paraplegia
- Sphingolipid